This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A. ROSTENBERG, Jr., M.D.; SAMUEL M. BLUEFARB, M.D.

AMA Arch Derm Syphilol. 1954;69(2):195-205.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE LYMPHOBLASTOMAS comprise an intriguing group of diseases of interest to workers in many fields of medicine. A major unsolved problem concerning the group is whether the members constitute clinical, pathologic, or etiologic entities, or whether they are essentially variations on the same theme. Surely among some of them there are adequate differences to determine clinical entities, but this, of course, does not mean that they are pathologic or etiologic entities; indeed, the bulk of the evidence would appear to be that they are not.^*

It occurred to us that a study of certain immunological reactions in these diseases would be of interest in at least two ways. First, from the point of view of the pathogenesis of the group, if the conditions were immunologically homogeneous, it would be some evidence for their etiologic and pathogenetic relatedness. Second, from the point of view of immunology, it is known that . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Department of Dermatology and the Allergy Unit, University of Illinois College of Medicine (Dr. Rostenberg), and the Department of Dermatology, Northwestern University Medical School and Cook County Hospital (Dr. Bluefarb).

Footnotes
Read at the Seventy-Third Annual Meeting of the American Dermatological Association, Lake Placid, N. Y. June 12, 1953.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?